|
Normal subjects with no known ocular disease
|
|
Normal subjects
|
37 (17 subjects)
|
32 (± 7)
|
17 F:14 M
|
9C: 2AA
|
37
|
|
Retinochoroidopathy secondary to retinal diseases
|
|
High myopia
|
13
|
29 (± 6.43)
|
11 M:2 F
|
9A: 4C
|
13
|
|
Hydroxychloroquine retinal toxicity
|
2
|
38 (N/A)
|
2 F
|
2C
|
2
|
|
Aged-related macular degeneration (drusen)
|
1
|
74 (NA)
|
1 M
|
1C
|
1
|
|
Central serous chorioretinopathy
|
2
|
48 (± 8.66)
|
2 M
|
2A
|
2
|
|
Cone-rod dystrophy
|
4
|
75 (± 0.57)
|
4 M
|
2C: 2A
|
4
|
|
Diabetic retinopathy
|
2
|
68 (N/A)
|
2 M
|
2C
|
2
|
|
Sickle cell retinopathy
|
1
|
48 (N/A)
|
1 F
|
1AA
|
1
|
|
Lymphoma (intraocular)
|
1
|
74 (N/A)
|
1 M
|
1C
|
1
|
|
Uveitic retinochoroidopathies
|
|
Panuveitis (idiopathic)
|
1
|
30 (N/A)
|
1 F
|
1C
|
1
|
|
Vogt-Koyanagi Harada
|
2
|
25 (N/A)
|
2 M
|
2AA
|
2
|
|
Acute zonal occult outer retinopathy
|
3
|
44 (± 21)
|
3 F
|
3C
|
3
|
|
Punctate inner choroidopathy
|
10
|
31 (± 6.67)
|
8 F:2 M
|
10C
|
10
|
|
Birdshot choroidoretinopathy
|
5
|
54 (± 4.54)
|
3 F:2 M
|
5C
|
5
|
|
Multifocal choroiditis
|
16
|
40 (± 8.03)
|
16 F
|
12C: 2AA: 2A
|
16
|
|
Sarcoidosis with posterior uveitis
|
2
|
83 (N/A)
|
2 F
|
2C
|
2
|
|
Serpiginous choroiditis
|
2
|
38 (N/A)
|
2 M
|
2C
|
2
|
|
Retinochoroiditis of unclear etiology
|
2
|
31 (N/A)
|
2 F
|
2AA
|
2
|
|
Total
|
69 (42 patients)
|
41 (± 16)
|
38 F:31 M
|
47C: 15A: 7AA
|
69
|
